These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36653660)
1. Safety, Efficacy and Distribution of Doxorubicin Loaded Radiopaque Beads in Chemoembolization in Intermediate Stage Hepatocellular Carcinoma (HCC) with Correlation with Local Response. Malagari Κ; Kiakidis T; Moschouris H; Deutsch M; Tanteles S; Pantou E; Panagiotou I; Koskinas J; Glantzounis GK; Alexopoulou A; Filippiadis D; Brountzos E; Kelekis N Cardiovasc Intervent Radiol; 2023 Mar; 46(3):337-349. PubMed ID: 36653660 [TBL] [Abstract][Full Text] [Related]
2. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma. Li J; Wang N; Shi C; Liu Q; Song J; Ye X J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307 [TBL] [Abstract][Full Text] [Related]
3. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study. Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558 [TBL] [Abstract][Full Text] [Related]
4. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up. Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569 [TBL] [Abstract][Full Text] [Related]
6. Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres. Albrecht KC; Aschenbach R; Diamantis I; Eckardt N; Teichgräber U J Cancer Res Clin Oncol; 2021 Jan; 147(1):23-32. PubMed ID: 32880029 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres Sun J; Zhou G; Xie X; Gu W; Huang J; Zhu D; Hu W; Hou Q; Shi C; Li T; Zhang X; Ji W; Ying S; Peng Z; Zhou J; Yu Z; Ji J; Du H; Guo X; Fang J; Han J; Xu H; Sun Z; Yu W; Shao G; Wu X; Hu H; Li L; Zheng J; Luo J; Chen Y; Cao G; Hu T Oncol Res; 2020 Feb; 28(1):75-94. PubMed ID: 31558180 [TBL] [Abstract][Full Text] [Related]
8. Transarterial Chemoembolization Using 100-μm Drug-Eluting Microspheres in Patients with Hepatocellular Carcinoma: A Prospective Study and Midterm Follow-up. Ou HY; Wu YN; Yu CY; Chen CL; Hsu HW; Weng CC; Leung-Chit Tsang L; Huang TL; Tong YS; Lim WX; Cheng YF J Vasc Interv Radiol; 2020 Nov; 31(11):1784-1791. PubMed ID: 33023805 [TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience. Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Cillo U; Guadagni S; Fiorentini G Future Oncol; 2017 Oct; 13(25):2243-2252. PubMed ID: 29063780 [TBL] [Abstract][Full Text] [Related]
10. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone. Brown KT; Do RK; Gonen M; Covey AM; Getrajdman GI; Sofocleous CT; Jarnagin WR; D'Angelica MI; Allen PJ; Erinjeri JP; Brody LA; O'Neill GP; Johnson KN; Garcia AR; Beattie C; Zhao B; Solomon SB; Schwartz LH; DeMatteo R; Abou-Alfa GK J Clin Oncol; 2016 Jun; 34(17):2046-53. PubMed ID: 26834067 [TBL] [Abstract][Full Text] [Related]
11. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis. Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514 [No Abstract] [Full Text] [Related]
12. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center. Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821 [TBL] [Abstract][Full Text] [Related]
13. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma. Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378 [TBL] [Abstract][Full Text] [Related]
14. Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma. Aliberti C; Carandina R; Sarti D; Mulazzani L; Pizzirani E; Guadagni S; Fiorentini G AJR Am J Roentgenol; 2017 Aug; 209(2):430-434. PubMed ID: 28537756 [TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of drug-eluting microspheres chemoembolization under cone beam computed tomography control in patients with early and intermediate stage hepatocellular carcinoma. Korsic S; Levasic N; Dezman R; Zupan LAL; Trotovsek B; Jansa R; Smid A; Popovic P Radiol Oncol; 2022 Aug; 56(3):311-318. PubMed ID: 35535426 [TBL] [Abstract][Full Text] [Related]
16. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995 [TBL] [Abstract][Full Text] [Related]
17. Super-selective transarterial chemoembolization of hepatocellular carcinoma with doxorubicin-eluting beads sized 40-75 microns: assessment of efficacy and safety. Ballı HT; Aikimbaev K Diagn Interv Radiol; 2020 Sep; 26(5):482-487. PubMed ID: 32815520 [TBL] [Abstract][Full Text] [Related]
18. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Reyes DK; Vossen JA; Kamel IR; Azad NS; Wahlin TA; Torbenson MS; Choti MA; Geschwind JF Cancer J; 2009; 15(6):526-32. PubMed ID: 20010173 [TBL] [Abstract][Full Text] [Related]
19. Radiopaque beads loaded with doxorubicin in the treatment of patients with hepatocellular carcinoma: A retrospective, multi-center study. Lakhoo J; Adams R; Dave A; Luo L; Vargo CJ; Isaacson AJ; Sher A; Fischman A; Yee DC; Ryan S; Patel S; Duchac D; Brown DB Cancer Treat Res Commun; 2020; 25():100208. PubMed ID: 32932173 [TBL] [Abstract][Full Text] [Related]
20. Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinoma. Urbano J; Echevarria-Uraga JJ; Ciampi-Dopazo JJ; Sánchez-Corral JA; Cobos Alonso J; Anton-Ladislao A; Peña-Baranda B; Nacarino-Mejias V; González-Costero R; Muñoz Ruiz-Canela JJ; Pérez-Cuesta J; Lanciego C; de Gregorio MA Eur J Radiol; 2020 May; 126():108966. PubMed ID: 32278280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]